Is Abcam a good dividend stock?

Abcam (OTCMKTS:ABCZY) pays an annual dividend of $0.07 per share and currently has a dividend yield of 0.36%. Read our dividend analysis for ABCZY .

How do I buy shares of Abcam?

Shares of ABCZY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does Abcam have any subsidiaries?

The following companies are subsidiares of Abcam: Abcam (US) Ltd., Abcam Trading (Shanghai) Co. Ltd., Abcam US Group Holdings Inc., and Epitomics Inc. Read More

OTCMKTS:ABCZY

Abcam (ABCZY) Stock Price, News & Analysis

→ This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad)

Free ABCZY Stock Alerts

Compare

Today's Range: N/A
50-Day Range: $19.40
▼
$19.40
52-Week Range: N/A

Volume: 5,400 shs
Average Volume: 4,712 shs
Market Capitalization: $3.98 billion

P/E Ratio: N/A
Dividend Yield: 0.36%
Price Target: N/A

Stock Analysis

Get Abcam alerts:

Ad DTI

Don’t expose yourself to stocks during the week

The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.

Click here and I’ll give you all the details.

About Abcam Stock (OTCMKTS:ABCZY)

Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Germany, the United Kingdom, and internationally. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex assays. Its research products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. The company also offers diagnostic and therapeutic solutions. The company also sells its products online. Abcam plc has partnership with Cancer Research UK for the development and commercialization of novel custom antibodies to support the acceleration of cancer research. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom.

Ad DTI

Don’t expose yourself to stocks during the week

Click here and I’ll give you all the details.

ABCZY Stock News Headlines

March 18, 2024 | msn.com

Long-standing Danaher executive Markus Lusser becomes new president of Abcam

March 18, 2024 | finance.yahoo.com

Abcam appoints Markus Lusser as new President

April 18, 2024 | Priority Gold (Ad)

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

November 7, 2023 | msn.com

Danaher deal for Abcam approved by 89 per cent of shareholders

November 6, 2023 | uk.news.yahoo.com

Abcam shareholders approve $5.7 billion Danaher deal

November 1, 2023 | thetimes.co.uk

Abcam founder ends fight to block takeover

October 23, 2023 | finance.yahoo.com

Leading Independent Proxy Advisor Glass Lewis Joins ISS in Recommending Shareholders Vote "FOR" Danaher Corporation’s Proposed Acquisition of Abcam

October 21, 2023 | msn.com

Efforts to stop takeover of biotech firm Abcam dealt a blow

April 18, 2024 | Priority Gold (Ad)

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

October 19, 2023 | msn.com

Top Abcam Investor HBK Voices Support for $5.7 Billion Sale

October 17, 2023 | stockhouse.com

Leading Proxy Advisor, ISS, Recommends Shareholders Vote "FOR" Danaher Corporation's Proposed Acquisition of Abcam

October 16, 2023 | proactiveinvestors.com

Exlusive: Why Abcam founder believes Danaher's acquisition offer falls short

October 16, 2023 | msn.com

HBK Capital Becomes Biggest Abcam Investor, Set to Support Sale

October 14, 2023 | msn.com

Abcam founder's concern over exodus of British life science companies

October 14, 2023 | msn.com

Abcam founder speaks out against growing exodus of British life science companies

October 12, 2023 | finance.yahoo.com

Independent Directors of Abcam Highlight Compelling Reasons for Shareholders to Support Proposed Sale to Danaher

October 5, 2023 | msn.com

Abcam received multiple bids in sales process, contacted over 30 parties

October 5, 2023 | ft.com

Life sciences group Abcam rejects founder’s accusations over $5.7bn deal with Danaher

October 4, 2023 | msn.com

Abcam challenger hits out as process to set EGM date goes on

September 28, 2023 | msn.com

Abcam founder slams £4.5bn sale to US conglomerate Danaher

September 28, 2023 | ca.news.yahoo.com

UK Life Sciences Firm Abcam’s Founder Fights $5.7 Billion Bid

September 15, 2023 | msn.com

UPDATE 3-Abcam founder seeks to block $5.7 billion Danaher deal

September 15, 2023 | msn.com

Signal: Danaher’s $5.7bn acquisition of Abcam faces stand-off with founder

September 14, 2023 | finance.yahoo.com

Abcam plc Statement on Dr. Jonathan Milner’s Announcement

September 14, 2023 | thetimes.co.uk

Abcam founder Jonathan Milner renews clear-out bid

September 14, 2023 | investing.com

Abcam plc founder to vote against proposed $5.7B Danaher acquisition, believes offer undervalues the company

September 14, 2023 | finance.yahoo.com

Dr. Jonathan Milner opposes Danaher's acquisition of Abcam and calls for EGM to replace Board

See More Headlines

Receive ABCZY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Industrial Inorganic Chemicals
Sub-Industry: N/A
Current Symbol: OTCMKTS:ABCZY
Previous Symbol: NASDAQ:ABCZY
CUSIP: N/A
CIK: N/A
Web: www.abcam.com
Phone: 44 1223 696 000
Fax: N/A
Employees: 1,492
Year Founded: 1998

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $336.37 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 205,080,000
Free Float: N/A
Market Cap: $3.98 billion
Optionable: Not Optionable
Beta: 1.29

Social Links

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Mr. Alan Thomas Hirzel BS (Age 52)
MS, MBA, CEO & Exec. Director
Mr. Michael Shaun Baldock (Age 54)
CFO & Director
Dr. Jonathan Simon Milner (Age 55)
Co-Founder & Non-Exec. Deputy Chairman
Mr. Mark Dermody
Interim CIO
James Staveley
VP of Investor Relations

Key Competitors

View All Competitors

ABCZY Stock Analysis - Frequently Asked Questions

Is Abcam a good dividend stock?: Abcam (OTCMKTS:ABCZY) pays an annual dividend of $0.07 per share and currently has a dividend yield of 0.36%.
Read our dividend analysis for ABCZY.
How do I buy shares of Abcam?: Shares of ABCZY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does Abcam have any subsidiaries?: The following companies are subsidiares of Abcam: Abcam (US) Ltd., Abcam Trading (Shanghai) Co. Ltd., Abcam US Group Holdings Inc., and Epitomics Inc.
Read More

This page (OTCMKTS:ABCZY) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial